In 2019, there were 1,202 cell therapy drugs active in various stages of clinical trials, compared to just over 400 in development in 2017. This statistic shows the active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type.
Active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Nature. (September 27, 2019). Active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type [Graph]. In Statista. Retrieved December 04, 2024, from https://www.statista.com/statistics/1093728/active-io-agents-in-drug-development-pipeline-by-therapy-global/
Nature. "Active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type." Chart. September 27, 2019. Statista. Accessed December 04, 2024. https://www.statista.com/statistics/1093728/active-io-agents-in-drug-development-pipeline-by-therapy-global/
Nature. (2019). Active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type. Statista. Statista Inc.. Accessed: December 04, 2024. https://www.statista.com/statistics/1093728/active-io-agents-in-drug-development-pipeline-by-therapy-global/
Nature. "Active Immuno-oncological Agents in The Global Drug Development Pipeline in 2017 and 2019, by Therapy Type." Statista, Statista Inc., 27 Sep 2019, https://www.statista.com/statistics/1093728/active-io-agents-in-drug-development-pipeline-by-therapy-global/
Nature, Active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type Statista, https://www.statista.com/statistics/1093728/active-io-agents-in-drug-development-pipeline-by-therapy-global/ (last visited December 04, 2024)
Active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type [Graph], Nature, September 27, 2019. [Online]. Available: https://www.statista.com/statistics/1093728/active-io-agents-in-drug-development-pipeline-by-therapy-global/
